| 臺大學術典藏 |
2022-06-27T07:06:31Z |
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: Associated genetic mutations and relationship to antimicrobial exposure
|
Wang J.-Y.; Lee L.-N.; Lai H.-C.; Wang S.-K.; Jan I.-S.; CHONG-JEN YU; Hsueh P.-R.; Yang. P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:29Z |
Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis
|
Wang J.-Y.; Lee L.-N.; Lai H.-C.; Hsu H.-L.; Jan I.-S.; CHONG-JEN YU; Hsueh P.-R.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:01:53Z |
Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan
|
Shu C.-C.; Ato M.; Wang J.-T.; Jou R.; Wang J.-Y.; Kobayashi K.; Lai H.-C.; CHONG-JEN YU; Lee L.-N.; Luh K.-T. |
| 臺大學術典藏 |
2022-06-27T07:01:42Z |
Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion
|
Shu C.-C.; Wang J.-Y.; Hsu C.-L.; Keng L.-T.; Tsui K.; Lin J.-F.; Lai H.-C.; CHONG-JEN YU; Lee L.-N.; Luh K.-T. |
| 臺大學術典藏 |
2022-06-27T07:00:12Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Wu C.-T.; Lai H.-C.; Lee L.-N.; Chiang B.-L.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T07:00:10Z |
Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells
|
Shu C.-C.; Wu M.-F.; Wang J.-Y.; Lai H.-C.; Lee L.-N.; Chiang B.-L.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T07:00:01Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:51Z |
Mono- and poly-functional T cells in nontuberculous mycobacteria lung disease patients: Implications in analyzing risk of disease progression
|
Shu C.-C.; Wu L.S.-H.; Wu M.-F.; Lai H.-C.; Wang P.-H.; Cheng S.-L.; Wang J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:48Z |
NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
|
Wu M.-F.; Shu C.-C.; Wang J.-Y.; Yan B.-S.; Lai H.-C.; Chiang B.-L.; Wu L.S.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-05-13T08:04:52Z |
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
|
Shu C.-C.; Lee L.-N.; Wu M.-F.; Lee C.-H.; JANN-TAY WANG; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; Wu V.-C.; Yu M.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:43Z |
Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan
|
Shu C.-C.; Ato M.; JANN-TAY WANG; Jou R.; Wang J.-Y.; Kobayashi K.; Lai H.-C.; Yu C.-J.; Lee L.-N.; Luh K.-T. |
| 臺大學術典藏 |
2022-05-10T08:09:24Z |
Month of birth and the risk of narcolepsy: a systematic review and meta-analysis
|
Hsu C.-W.; Tseng P.-T.; YU-KANG TU; Lin P.-Y.; Wang L.-J.; Hung C.-F.; Yang Y.-H.; Kao H.-Y.; Yeh C.-B.; Lai H.-C.; Chen T.-Y. |
| 臺大學術典藏 |
2022-05-03T06:19:32Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; SHU-HUI CHANG; Lai H.-C.; Chen T.H.-H. |
| 臺大學術典藏 |
2022-04-21T06:51:43Z |
Community-Based Multiple Screening Model: Design, Implementation, and Analysis of 42,387 Participants Taiwan Community-Based Integrated Screening Group
|
Chen, Tony Hsiu Hsi; Chiu Y.-H.; Luh D.-L.; Yen M.-F.; Wu H.-M.; Chen L.-S.; Tung T.-H.; Huang C.-C.; Chan C.-C.; Shiu M.-N.; Yeh Y.-P.; Liou H.-H.; Liao C.-S.; Lai H.-C.; Chiang C.-P.; Peng H.-L.; Tseng C.-D.; Yen M.-S.; Hsu W.-C.; Chen C.-H. |
| 臺大學術典藏 |
2022-04-21T06:51:31Z |
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries
|
Wu G.H.-M.; Wang Y.-W.; Yen A.M.-F.; Wong J.-M.; Lai H.-C.; Warwick J.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:17Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; Chang S.-H.; Lai H.-C.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-03-24T07:01:35Z |
Quantifying spatial heterogeneity of vulnerability to short-term PM2.5 exposure with data fusion framework
|
Kuo C.-P.; Fu J.S.; Wu P.-C.; Cheng T.-J.; Chiu T.-Y.; Huang C.-S.; CHANG-FU WU; Lai L.-W.; Lai H.-C.; Liang C.-K. |
| 臺大學術典藏 |
2022-03-24T03:27:41Z |
Community-Based Multiple Screening Model: Design, Implementation, and Analysis of 42,387 Participants Taiwan Community-Based Integrated Screening Group
|
Chen T.H.-H.; Chiu Y.-H.; Luh D.-L.; Yen M.-F.; Wu H.-M.; Chen L.-S.; Tung T.-H.; Huang C.-C.; CHANG-CHUAN CHAN; Shiu M.-N.; Yeh Y.-P.; Liou H.-H.; Liao C.-S.; Lai H.-C.; Chiang C.-P.; Peng H.-L.; Tseng C.-D.; Yen M.-S.; Hsu W.-C.; Chen C.-H. |
| 臺大學術典藏 |
2022-03-04T05:33:31Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; CHEN-TU WU; Lai H.-C.; Lee L.-N.; Chiang B.-L.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-18T08:26:03Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:43Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:33Z |
Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients
|
Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; Hsu S.-J.; Lai H.-C.; Su C.-W.; CHUN-JEN LIU; Peng C.-Y.; Yu M.-L. |
